Logo for Optimi Health Corp.
OPTI

Optimi Health Corp.

Status
Active
Issued & Outstanding89,060,899
Reserved for Issuance8,251,945
Currency
CSE Index

About

Optimi Health Corp.

Listing date
February 23, 2021

Optimi Health is an end-to-end Canadian-based drug researcher and formulator licensed by Health Canada to produce and supply psychedelic substances such as 3,4-Methylenedioxymethamphetamine (“MDMA”) and natural, GMP-grade psilocybin, as well as functional mushrooms that focus on the health and wellness markets. Built with the purpose of producing scalable psychedelic formulations for transformational human experiences, the Company’s goal is to be the number one trusted, compassionate supplier of safe drug products throughout the world. Optimi’s products are grown at its two facilities comprising a total of 20,000 square feet in Princeton, British Columbia, making it the largest psilocybin and MDMA producer in North America.